- Home
- KPTI vs CLPR Comparison
KPTI vs CLPR Comparison
Compare KPTI & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | CLPR |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.6M | 46.4M |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KPTI | CLPR |
|---|---|---|
| Price | $1.96 | $3.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 67.5K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 10.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $109,997,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.36 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.57 | ★ 5.82 |
| 52 Week Low | $1.79 | $2.69 |
| 52 Week High | $10.99 | $4.61 |
Technical Indicators
Market Signals| Indicator | KPTI | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 22.86 | 65.67 |
| Support Level | N/A | $2.79 |
| Resistance Level | $2.18 | $3.58 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.15 | 0.04 |
| Stochastic Oscillator | 34.62 | 78.15 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.